dievini Hopp Biotech Holding logo

dievini Hopp Biotech Holding

Europe, Baden-Wurttemberg, Germany, Walldorf

Description

dievini Hopp Biotech Holding is a German company dedicated to the support and coaching of life and health sciences companies.

Investor Profile

dievini Hopp Biotech Holding has made 19 investments, with 0 in the past 12 months and 68% as lead.

Stage Focus

  • Series D (26%)
  • Series C (21%)
  • Post Ipo Equity (16%)
  • Series F (11%)
  • Series E (11%)
  • Series Unknown (5%)
  • Private Equity (5%)
  • Series B (5%)

Country Focus

  • Germany (95%)
  • Switzerland (5%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Health Care
  • Pharmaceutical
  • Medical
  • Biopharma
  • Health Diagnostics
  • Information Technology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does dievini Hopp Biotech Holding frequently co-invest with?

Co-Investments: 1
Wellington Partners
Europe, Bayern, Germany, Munich
Co-Investments: 5
Baillie Gifford
Europe, Edinburgh, City of, United Kingdom, Edinburgh
Co-Investments: 1
Bill & Melinda Gates Foundation
North America, New York, United States, New York
Co-Investments: 1
Sigma Group
North America, New Jersey, United States, Saddle River
Co-Investments: 1
Co-Investments: 1
Northview LifeSciences
North America, British Columbia, Canada, Vancouver
Co-Investments: 1
AI
Europe, Bayern, Germany, Munich
Co-Investments: 5
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 1
Redmile Group
North America, California, United States, San Francisco
Co-Investments: 1

What are some of recent deals done by dievini Hopp Biotech Holding?

Novaliq

Heidelberg, Baden-Wurttemberg, Germany

Novaliq is a pharmaceutical company for the development and commercialization of first- and best-in-class ocular therapeutics.

BiotechnologyHealth CarePharmaceutical
Series UnknownApr 12, 2022
Amount Raised: $15,048,306
Heidelberg Pharma

Ladenburg, Baden-Wurttemberg, Germany

Heidelberg Pharma GmbH is a company providing pre-clinical drug discovery and development services.

BiotechnologyHealth CarePharmaceutical
Post Ipo EquityApr 27, 2020
Amount Raised: $15,587,705
immatics biotechnologies

Tübingen, Baden-Wurttemberg, Germany

Immatics is a biopharmaceutical company focused on the development of immunotherapeutic substances for cancer therapy.

BiotechnologyMedicalTherapeutics
Post Ipo EquityMar 17, 2020
Amount Raised: $104,000,000
Heidelberg Pharma

Ladenburg, Baden-Wurttemberg, Germany

Heidelberg Pharma GmbH is a company providing pre-clinical drug discovery and development services.

BiotechnologyHealth CarePharmaceutical
Post Ipo EquityJan 22, 2020
Amount Raised: $16,643,717
Novaliq

Heidelberg, Baden-Wurttemberg, Germany

Novaliq is a pharmaceutical company for the development and commercialization of first- and best-in-class ocular therapeutics.

BiotechnologyHealth CarePharmaceutical
Series FOct 11, 2018
Amount Raised: $53,000,000
immatics biotechnologies

Tübingen, Baden-Wurttemberg, Germany

Immatics is a biopharmaceutical company focused on the development of immunotherapeutic substances for cancer therapy.

BiotechnologyMedicalTherapeutics
Series EOct 4, 2017
Amount Raised: $58,000,000
Molecular Health

Heidelberg, Baden-Wurttemberg, Germany

Molecular Health offers software solutions for evidence-based healthcare decision support and smarter drug development.

BiotechnologyHealth CareHealth DiagnosticsInformation TechnologyMedical
Private EquityNov 16, 2015
Amount Raised: $26,712,712
CureVac

Tübingen, Baden-Wurttemberg, Germany

CureVac is a clinical-stage biopharmaceutical company that provides prophylactic and therapeutic application of messenger RNA.

BiopharmaBiotechnologyTherapeutics
Series FNov 3, 2015
Amount Raised: $107,974,788
immatics biotechnologies

Tübingen, Baden-Wurttemberg, Germany

Immatics is a biopharmaceutical company focused on the development of immunotherapeutic substances for cancer therapy.

BiotechnologyMedicalTherapeutics
Series DJul 16, 2014
Amount Raised: $29,756,551
AC Immune

Lausanne, Vaud, Switzerland

AC Immune is a biopharmaceutical company focused on neurodegenerative diseases with three product candidates in clinical trials

BiotechnologyPharmaceuticalTherapeutics
Series DJan 9, 2014
Amount Raised: $22,033,469